Peptides vs SARMs vs Steroids
Three different mechanisms, three different legal positions, three very different evidence bases. What they are not is a safety ladder — and the honest comparison does not flatter the option we sell.
This guide compares three compound classes on mechanism, effect size, legal status and risk. Peptides Costa Rica does not sell SARMs or anabolic steroids; both are discussed here for comparison only. This is educational content, not medical advice. Sources are listed at the end.
The framing you usually meet is a spectrum: steroids at the dangerous end, SARMs in the middle as a "safer" version, peptides at the gentle end as the natural option. It is tidy, it is how these compounds get sold, and it is wrong in several directions at once.
These are three unrelated mechanisms. Two of them act on the androgen receptor and one does not. One class has decades of pharmaceutical trials behind it, one has almost none, and the third depends entirely on which compound you mean. Sorting them by perceived risk obscures every distinction that actually matters.
The Short Answer
If you read nothing else
Anabolic steroids build the most muscle by a wide margin, and that is not a close call in the trial data. SARMs use the same receptor with a fraction of the evidence and no approval anywhere — they are not a milder steroid, they are an unapproved drug with a documented product-quality crisis. Peptides are not a substitute for either, because most of them are not anabolic in the same sense at all; the growth-hormone ones increase lean mass without reliably increasing strength. And "peptide" is not a safety category: several are banned in sport, and some carry serious risks of their own.
Three Different Mechanisms
The categories are defined by chemistry and target, not by how risky they feel.
Anabolic-androgenic steroids
Modified derivatives of testosterone. Small fat-soluble molecules that bind the androgen receptor directly in muscle and everywhere else it appears — prostate, skin, liver, brain.
SARMs
Non-steroidal small molecules built to bind the same androgen receptor but with tissue selectivity — the design goal being muscle and bone effects without prostate and hair consequences.
Peptides
Short amino acid chains. Not androgenic at all. They act on entirely different receptor systems — growth hormone release, GLP-1, melanocortin, healing pathways — depending on the compound.
That last point does most of the work. Grouping "peptides" as one thing is like grouping "pills" as one thing. A GH secretagogue, a GLP-1 agonist and a healing peptide have almost nothing in common beyond being made of amino acids. Our guide on how peptides work in the body covers that spread, and are peptides steroids? handles the specific confusion.
What Actually Builds Muscle
This is the comparison most people are actually running, and it has a clear answer that happens to cut against the category we sell. Here it is anyway.
The reference point is a 1996 trial published in the New England Journal of Medicine. Forty-three men were randomised to placebo or 600 mg of testosterone enanthate weekly for ten weeks, with or without supervised weight training. Fat-free mass rose by about 2.0 kg with training alone, about 3.2 kg with testosterone and no training at all, and about 6.1 kg with both. Bench press one-rep max rose 38% in the testosterone-plus-training group against 11% for training alone.
Read the middle number again. Injecting testosterone while doing nothing produced more fat-free mass than training hard for ten weeks. That is the honest scale of the effect, and it explains why the practice persists despite the risks.
Now the growth-hormone comparison. A 2008 systematic review in the Annals of Internal Medicine pooled 27 randomised controlled trials in young, lean, physically fit participants. Growth hormone increased lean body mass by 2.1 kg. Strength did not improve. Exercise capacity did not improve, and lactate levels during exercise were higher in two of the three studies measuring it. Soft tissue swelling and fatigue were more common. The authors concluded that claims growth hormone enhances physical performance are not supported by the literature.
Lean mass and strength are not the same outcome. A compound can move the first without moving the second.
One study made the comparison directly. In older adults given growth hormone, testosterone, or both, growth hormone alone did not improve strength or exercise capacity — testosterone alone and the combination did. That is the cleanest available statement of the difference.
SARMs sit between the two in theory. In practice the human efficacy data is thin: no SARM has ever demonstrated sufficient safety and efficacy to gain approval from either the FDA or the EMA, despite roughly a dozen pharmaceutical companies working on them since the mid-1990s.
Legal Status
| Class | Approval | Sport |
|---|---|---|
| Anabolic steroids | Testosterone and several derivatives are approved medicines for defined conditions. Non-medical possession is a criminal matter in many countries — a Schedule III controlled substance in the US | Prohibited at all times under WADA's anabolic agents category |
| SARMs | Not approved by any regulator, anywhere, for any indication. Sold as "research chemicals" or spiked into supplements. The FDA has issued consumer warnings and warning letters | Prohibited by WADA since 2008, with several named individually |
| Peptides | Depends entirely on the compound. Insulin, GLP-1 drugs and somatropin are approved medicines. Most research peptides are not approved anywhere | Varies. Growth hormone and secretagogues are prohibited; several others are named individually or captured by the non-approved substances clause |
The sport column deserves emphasis because it is where the "peptides are the safe alternative" framing collapses fastest. An athlete switching from a steroid to a GH secretagogue has not moved to a permitted compound. They have moved to a different prohibited one. Anyone subject to testing should assume prohibition and confirm with their national anti-doping organisation rather than reasoning by category.
Risk Profiles
These do not stack neatly, because the risks are qualitatively different rather than larger and smaller versions of each other.
| Class | Principal documented risks | How well characterised |
|---|---|---|
| Anabolic steroids | Suppression of natural testosterone production, which may not recover; adverse lipid changes; raised haematocrit; cardiac effects; liver strain with oral forms; fertility impairment; mood effects | Extensively. Decades of clinical and epidemiological literature |
| SARMs | Suppression of endogenous testosterone; liver injury; the FDA has specifically warned of increased risk of heart attack and stroke; adverse cholesterol changes | Poorly. Case reports and short trials, with no long-term data |
| GH-axis peptides | Fluid retention, joint pain, carpal tunnel symptoms, reduced insulin sensitivity and raised blood glucose | Moderately, largely by extrapolation from growth hormone replacement studies |
| Other peptides | Entirely compound-specific — GLP-1 gastrointestinal effects, melanocortin pigmentation and cardiovascular effects, and so on | Ranges from extensive to none at all |
The comparison that misleads people most
"Peptides are safer than steroids" treats a well-characterised risk as worse than an uncharacterised one. Testosterone's downsides are unpleasant and well documented, which means they can be monitored, anticipated and in many cases managed by a clinician. For most research peptides there is no long-term safety data at all — not reassuring data, no data. Those are different situations, and the second is not automatically the better one. It is simply the one where nobody has looked.
The Quality Problem
One issue cuts across all three categories and is worse in the unregulated ones than most buyers realise.
In 2017, researchers from the US Anti-Doping Agency, Harvard and the Uniformed Services University bought 44 products sold online as SARMs and analysed them using anti-doping laboratory methods. The results, published in JAMA, are worth stating precisely:
- Only 23 of 44 products (52%) contained any SARM at all.
- A further 17 products (39%) contained a different unapproved drug — including the growth hormone secretagogue ibutamoren, the PPAR-δ agonist GW501516 and the Rev-ErbA agonist SR9009.
- Only 18 (41%) contained the amount stated on the label.
- 11 (25%) contained substances not listed on the label at all.
Roughly half of what people bought was not what they thought they were buying, and two in five contained a different unapproved drug entirely. Later analyses of products sold in the UK, Australia and Italy found the same pattern.
This applies to research peptides too — the supply chain is the same kind of supply chain. The difference is that it is checkable. Batch-specific identity and purity testing exists, and a supplier either shows it to you or does not. Our guides on understanding peptide purity and COAs and research versus pharmaceutical peptides cover how to read the documentation, and our COA database holds the results for what we carry.
Where Peptides Genuinely Differ
Having spent the page dismantling the marketing version, here is the defensible version.
Different goals entirely
Most peptides are not competing with steroids. Healing, sleep, appetite regulation and pigmentation are not outcomes an androgen delivers, and comparison on muscle mass misses the point.
They work through your own systems
GH secretagogues prompt the pituitary to release its own hormone within existing feedback loops. That is mechanistically different from supplying an exogenous hormone at supraphysiological levels.
No androgen receptor involvement
The specific consequences of androgen suppression — shutdown, fertility effects, prostate and hair effects — are not on the table, because that receptor is not being touched.
Some are approved medicines
The GLP-1 class in particular has large phase 3 trial programmes and regulatory approval, which is more than any SARM has ever achieved.
What none of that supports is "peptides instead of steroids for muscle." If maximum muscle is the goal, the compounds that deliver it are the androgenic ones, and the honest conversation is about whether you are willing to accept their consequences — a conversation to have with a doctor, not a supplier. The peptides that get pitched as an alternative do something different and less dramatic, and pretending otherwise sets people up for disappointment.
Common Questions
Are peptides just weak steroids?
No — they are chemically unrelated and act on different receptors entirely. Steroids are lipid-based molecules that bind the androgen receptor; peptides are amino acid chains acting on their own receptor systems. Calling them weak steroids gets both the mechanism and the expectations wrong.
Are SARMs safer than steroids?
That was the design intent and it has not been demonstrated. No SARM has passed the safety and efficacy bar for approval anywhere, they suppress natural testosterone as steroids do, and the FDA has warned specifically about liver injury, heart attack and stroke. You also have roughly a coin-flip chance of the product containing what the label says. Fewer known risks is not the same as fewer risks.
Do peptides suppress natural testosterone?
GH-axis peptides do not — they operate on a separate hormonal system and do not touch the testosterone feedback loop. This is a genuine and meaningful difference from both steroids and SARMs. It is compound-specific, though, and not something to assume of any molecule that happens to be a peptide.
Can they be combined?
People do, and the combinations are not studied. Stacking an androgen with a GH secretagogue means layering two effects on glucose handling and cardiovascular load with no interaction data. It also makes any adverse effect impossible to attribute. See our page on peptide drug interactions.
Which shows up on a drug test?
Under WADA testing, potentially all three. Steroids and SARMs are both explicitly prohibited, and growth hormone and its secretagogues are too. Standard workplace drug panels typically screen for none of them, which is a different question from anti-doping testing and is often confused with it.
Is TRT the same as steroid use?
Same molecule, different context. Testosterone replacement restores physiological levels in someone with diagnosed deficiency, under medical supervision with monitoring. Performance use means supraphysiological doses without a medical indication. The dose, the intent and the risk profile all differ — and the 600 mg weekly used in the trial above is several times a typical replacement dose.
Do you sell SARMs or steroids?
No. Our catalogue is research peptides and related compounds. We have written this page because the comparison comes up constantly and the versions circulating online are mostly marketing, but there is nothing on this page we are selling you as a result of it.
What should I actually do if I want more muscle?
Get training, protein intake and sleep genuinely dialled in first, because the ceiling on those is higher than most people reach and nothing here compensates for missing them. If you have done that and still want to look at pharmacology, the conversation belongs with a doctor who can run bloodwork — not with a comparison page, ours included.
Is any of this legal in Costa Rica?
The peptides we carry are sold here as research compounds and are not approved as finished pharmaceutical drugs by the Ministerio de Salud, the FDA or the EMA. Anabolic steroids are controlled substances in many jurisdictions and SARMs are unapproved drugs everywhere, so anyone considering either should check their own legal position rather than assume. Our FAQ page covers how ordering works locally.
Want a straight answer about what fits your goal?
Tell us what you're actually trying to achieve and we'll give you an honest read — including when the answer is "nothing we sell" or "talk to a doctor first." No pressure, no upsell.
Contact Us on WhatsAppImportant disclaimer: The information in this guide is general educational content only. It is not medical advice, a prescription, or a personalized recommendation, and nothing here should be read as encouraging the use of any compound discussed. Peptides Costa Rica does not sell selective androgen receptor modulators or anabolic-androgenic steroids; both are described here for comparison only. No dosing guidance for any class is provided on this page. Anabolic-androgenic steroids are approved medicines for defined conditions in many countries and are simultaneously controlled substances whose non-medical possession or supply is a criminal matter in numerous jurisdictions, including the United States; readers should establish their own legal position. No SARM has been approved by the FDA, the EMA, or any other regulatory authority for any indication, and the FDA has issued public warnings regarding risks including liver injury, heart attack and stroke. Most research peptides, including those sold by Peptides Costa Rica, are not approved by the FDA, the EMA, or Costa Rica's Ministerio de Salud as finished pharmaceutical drugs and are intended for laboratory and research purposes only; a minority of peptide medicines, such as insulin, somatropin and the GLP-1 receptor agonists, hold approvals for specific indications. The effect sizes cited are drawn from separate published studies in different populations over different durations and are not the product of a head-to-head trial. Anabolic steroids, SARMs, growth hormone and growth hormone secretagogues are all prohibited under the World Anti-Doping Code, and several other peptides are prohibited either by name or under the non-approved substances clause; athletes should confirm the status of any compound with their national anti-doping organisation. Suppression of endogenous testosterone, cardiovascular effects, liver injury, impaired glucose handling and fertility effects are documented for one or more of the classes described. Always consult a qualified healthcare professional before beginning any protocol. Products sold by Peptides Costa Rica are intended for laboratory and research purposes only.
- New England Journal of Medicine (Bhasin et al., 1996): Randomised trial of 600 mg testosterone enanthate weekly for ten weeks in 43 men, with and without strength training; fat-free mass increases of approximately 2.0 kg for training alone, 3.2 kg for testosterone alone and 6.1 kg for the combination.
- Annals of Internal Medicine (Liu et al., 2008): Systematic review of 27 randomised controlled trials of growth hormone in healthy young participants; lean body mass increased 2.1 kg while strength and exercise capacity did not improve, with more frequent soft tissue oedema and fatigue.
- Annals of Internal Medicine (Liu et al., 2007): Systematic review of growth hormone in the healthy elderly, finding small body composition changes alongside increased adverse events and concluding it cannot be recommended as an anti-aging therapy.
- Blackman et al. (2002), reported in the growth hormone literature: In older adults, growth hormone alone did not improve strength or exercise capacity, whereas testosterone alone and the combination did.
- JAMA (Van Wagoner, Eichner, Bhasin, Deuster & Eichner, 2017): Chemical analysis of 44 products sold online as SARMs — 52% contained a SARM, 39% contained a different unapproved drug, 41% matched the labelled amount and 25% contained unlisted substances.
- Drug Testing and Analysis (Leaney et al., 2021) and Sexual Medicine (Gaudiano et al., 2024): Independent analyses of SARM products sold in the UK and Italy reproducing the same labelling and content discrepancies.
- U.S. Food and Drug Administration: Public advisory on SARMs in bodybuilding products, citing increased risk of heart attack, stroke and liver damage, together with associated warning letters.
- World Anti-Doping Agency: Prohibited List — anabolic agents including anabolic-androgenic steroids and SARMs, peptide hormones and growth factors, and the non-approved substances category.
- Endocrine Reviews (Pope et al., 2014): Endocrine Society scientific statement on the adverse health consequences of performance-enhancing drugs.
